HomeReleases

Releases

CrankWheel Secures Summer 2026 Leader Award on SourceForge

Releases

CrankWheel Secures Summer 2026 Leader Award on SourceForge

CrankWheel has been named a Summer 2026 Leader in screen sharing software by SourceForge, landing in the top 5% of over 100,000 products listed on the platform. The recognition highlights the Reykjavik-based company’s ability to drive sales momentum by eliminating download friction during critical prospect discovery calls.

Money Talk·Jul 21
Molicel Targets Hybrid Market with Ultra-High-Power Battery Cell

Releases

Molicel Targets Hybrid Market with Ultra-High-Power Battery Cell

As global automotive demand pivots toward hybrids, Molicel has introduced its INR-21700-P70X cell, a power-dense battery designed to mimic supercapacitor performance. Unveiled at AABC Europe 2026, the technology promises to address the unique energy requirements of vehicles that rely on rapid power bursts and frequent, shallow cycling.

Sabre Taps Walt & Company to Lead Global Communications Strategy

Releases

Sabre Taps Walt & Company to Lead Global Communications Strategy

Campbell-based Silicon Valley agency Walt & Company has secured a contract as the agency of record for Sabre, the AI-native technology firm. The partnership aims to amplify Sabre’s market presence and articulate its role in reshaping the global travel ecosystem through cloud-based data and automated retailing solutions.

Money Talk·Jul 21
Augustus Hits $1 Billion Valuation to Modernize Global Dollar Access

Releases

Augustus Hits $1 Billion Valuation to Modernize Global Dollar Access

With a fresh $180 million in Series B funding led by Tiger Global, New York-based fintech Augustus has reached unicorn status. The company is leveraging its conditional U.S. national bank charter to bypass legacy correspondent banking, offering international institutions direct, programmable access to dollar rails through its proprietary infrastructure.

Investors Scrutinize Pentair Following 15% Stock Slump

Releases

Investors Scrutinize Pentair Following 15% Stock Slump

A 15% single-day stock drop for Pentair plc has triggered a securities fraud investigation by the law firm Bleichmar Fonti & Auld LLP. The inquiry focuses on whether the water solutions company misled shareholders regarding inventory levels within its highly profitable Pool segment during a sudden executive departure.

IBM Faces Securities Fraud Probe After 25 Percent Stock Plunge

Releases

IBM Faces Securities Fraud Probe After 25 Percent Stock Plunge

A 25 percent collapse in IBM’s share price on July 14, 2026, has triggered a formal investigation by Bleichmar Fonti & Auld LLP. The firm is probing whether the technology giant misled investors regarding the status of pending business deals and the health of its critical IBM Z product line.

Zillow Faces Securities Class Action Over Alleged Redfin Antitrust Deal

Releases

Zillow Faces Securities Class Action Over Alleged Redfin Antitrust Deal

Investors have launched a securities fraud class action against Zillow Group following a 17% stock plunge triggered by revelations of an allegedly anticompetitive $100 million agreement with Redfin. The lawsuit, filed in the U.S. District Court for the Western District of Washington, claims the company misled shareholders regarding the deal's true purpose.

Money Talk·Jul 21
GRAIL Faces Securities Class Action After NHS-Galleri Trial Failure

Releases

GRAIL Faces Securities Class Action After NHS-Galleri Trial Failure

A 50.55% collapse in GRAIL, Inc. stock following the failure of its flagship cancer screening trial has triggered a securities fraud class action. Investors allege the company misled them regarding the design and viability of the NHS-Galleri study, which failed to meet its primary endpoint in February 2026.

Money Talk·Jul 21
Insulet Faces Securities Fraud Class Action Over Omnipod Safety

Releases

Insulet Faces Securities Fraud Class Action Over Omnipod Safety

A federal securities fraud lawsuit now targets Insulet Corporation and its senior executives following revelations of manufacturing defects in the company's flagship Omnipod insulin delivery systems. The litigation, filed in the District of Massachusetts, alleges the company misled investors regarding product safety and its ability to maintain quality control.

Money Talk·Jul 21
Peabody Energy Faces Class Action Over Centurion Mine Production Claims

Releases

Peabody Energy Faces Class Action Over Centurion Mine Production Claims

A federal securities class action lawsuit has been filed against Peabody Energy Corporation following revelations that the company misled investors regarding production capabilities at its flagship Centurion hard coking coal mine, a failure that triggered a sharp 9.7% decline in the company’s stock price this past March.

Planet Fitness Faces Class Action After Marketing Pivot Triggers Sell-Off

Releases

Planet Fitness Faces Class Action After Marketing Pivot Triggers Sell-Off

A 31% collapse in Planet Fitness stock following a failed marketing campaign has prompted a securities fraud class action lawsuit. Investors allege the company misled them regarding the effectiveness of its strategy, which alienated the core base of casual gym-goers and resulted in stunted membership growth during the critical first quarter.

ZoomInfo Faces Securities Class Action After AI Strategy Flop

Releases

ZoomInfo Faces Securities Class Action After AI Strategy Flop

A 33% plunge in ZoomInfo Technologies stock has triggered a securities fraud class action lawsuit, with investors alleging the company misled them about the effectiveness of its AI-integrated products. The litigation, filed in the Western District of Washington, centers on claims that management masked declining customer retention.

Money Talk·Jul 21
Hub Group Faces Securities Class Action After Financial Restatements

Releases

Hub Group Faces Securities Class Action After Financial Restatements

Investors have launched a securities fraud class action against Hub Group Inc. following a series of accounting disclosures that forced the company to retract years of financial reports. The litigation, filed in the Northern District of Illinois, targets senior executives over claims that misstated earnings triggered significant stock price declines.

Money Talk·Jul 21
Microsoft Faces Securities Class Action Following Copilot Revenue Miss

Releases

Microsoft Faces Securities Class Action Following Copilot Revenue Miss

A 10% single-day stock plunge has triggered a securities fraud class action against Microsoft, with investors alleging the company misled the market about the stability and adoption rates of its Copilot AI. The lawsuit centers on claims that hidden functionality flaws dampened user growth, directly impacting Azure revenues.

Money Talk·Jul 21
Embecta Investors File Class Action Following 57% Stock Plunge

Releases

Embecta Investors File Class Action Following 57% Stock Plunge

A federal securities fraud lawsuit now targets Embecta Corp. and its senior leadership, alleging the medical device company misled shareholders regarding the market performance of its insulin pen portfolio. The litigation follows a catastrophic 57.8% single-day collapse in the company’s stock price recorded on May 5, 2026.

Seoul Retains Global Top Spot in QS Student Cities Ranking

Releases

Seoul Retains Global Top Spot in QS Student Cities Ranking

For the second consecutive year, Seoul has secured the top position in the QS Best Student Cities Ranking 2027, maintaining its lead over Tokyo and London. The South Korean capital continues to dominate due to its dense concentration of high-ranking academic institutions and a robust international student strategy.

Money Talk·Jul 21
US Housing Market Shifts Toward Buyers as Inventory Dynamics Evolve

Releases

US Housing Market Shifts Toward Buyers as Inventory Dynamics Evolve

The American housing market is experiencing its most buyer-friendly spring since 2018, with 70% of the 100 largest metropolitan areas now favoring buyers or trending in that direction. According to the latest Realtor.com Market Clock data, this shift marks a significant departure from the seller-dominated landscape of recent years.

Seoul Retains Global Top Spot in QS Student Cities Ranking

Releases

Seoul Retains Global Top Spot in QS Student Cities Ranking

For the second consecutive year, Seoul holds the title of the world’s premier study destination, anchoring an Asian dominance in the QS Best Student Cities Ranking 2027. Tokyo maintains its second-place position, while London rounds out the top three, continuing to leverage its historic concentration of elite academic institutions.

Playroll Secures Second Consecutive Global HR Provider Title

Releases

Playroll Secures Second Consecutive Global HR Provider Title

London-based HR platform Playroll has claimed two Gold Stevie® Awards, successfully defending its title as Global HR Solution Provider of the Year. The firm’s victory highlights a deliberate strategic pivot: deploying artificial intelligence to accelerate administrative tasks while expanding its reliance on human experts for high-stakes compliance and payroll decisions.

Money Talk·Jul 21
Veralto Targets Asia-Pacific Growth with Alfaa UV Acquisition

Releases

Veralto Targets Asia-Pacific Growth with Alfaa UV Acquisition

Veralto Corporation is scaling its industrial water treatment footprint by acquiring Alfaa UV, a Mumbai-based specialist in ultraviolet purification. The deal integrates the Indian firm into Veralto’s Trojan Technologies business, positioning the company to capture rising demand for sustainable water solutions across the pharmaceutical and food production sectors in Asia.

Money Talk·Jul 21
Cango Inc. Executes 10-for-1 Reverse Stock Split

Releases

Cango Inc. Executes 10-for-1 Reverse Stock Split

Ten shares of Cango Inc. stock have been condensed into one as the company’s 10-for-1 share consolidation took effect at 5:00 P.M. U.S. Eastern Time on July 20, 2026. The move significantly recalibrates the company's equity structure while maintaining its existing ticker symbol on the New York Stock Exchange.

Money Talk·Jul 21
Synchrony Financial Declares Dividends Following Q2 2026 Results

Releases

Synchrony Financial Declares Dividends Following Q2 2026 Results

Stamford-based Synchrony Financial has posted its fiscal results for the second quarter of 2026, coupling the earnings disclosure with a commitment to shareholder returns. The consumer financing firm confirmed a quarterly cash dividend of $0.34 per share of common stock, payable to investors later this summer.

Money Talk·Jul 21
AI Agents Collapse the Economics of Cyber Exploitation

Releases

AI Agents Collapse the Economics of Cyber Exploitation

Autonomous AI agents can now transform disclosed vulnerabilities into verified exploits for a median cost of $2.83 and just 11 minutes of labor. This shift effectively dismantles the economic scarcity that has historically protected enterprises, rendering traditional human-centric risk metrics like the CISA KEV catalog largely obsolete in an automated landscape.

Money Talk·Jul 21
Ceragon Networks Lands $70 Million Deal with APAC Mobile Operator

Releases

Ceragon Networks Lands $70 Million Deal with APAC Mobile Operator

A long-standing Tier-1 mobile operator in the Asia-Pacific region has awarded Ceragon Networks a five-year contract valued at approximately $70 million. The agreement focuses on the modernization of the client's nationwide 4G and 5G infrastructure through advanced wireless transport solutions and dedicated technical support.

Ransomware Surge: New Groups and AI Efficiency Drive Record Attacks

Releases

Ransomware Surge: New Groups and AI Efficiency Drive Record Attacks

Ransomware activity surged 60% in the second half of the 2026 reporting period, culminating in a four-year record of 861 victim disclosures in March alone. According to Black Kite’s latest research, the ecosystem has shifted from a few dominant players to a fragmented, highly operationalized market fueled by new entrants.

Phanes Therapeutics Expands Merck Collaboration for Biliary Tract Cancer

Releases

Phanes Therapeutics Expands Merck Collaboration for Biliary Tract Cancer

Phanes Therapeutics has broadened its clinical partnership with Merck, moving to test the bispecific antibody spevatamig alongside KEYTRUDA and chemotherapy. This expanded study targets frontline treatment for biliary tract cancer, a disease characterized by significant medical challenges and a high demand for more effective therapeutic interventions.

Money Talk·Jul 21